PHARMACEUTICAL COMPOSITION FOR PARENTERAL DROP INTRODUCTION Russian patent published in 2020 - IPC A61K9/08 A61K31/122 A61K31/164 A61K31/198 A61K31/375 A61K31/385 A61K31/4188 A61K31/513 A61K31/519 A61K31/675 A61K31/704 A61K31/7076 A61K31/7084 A61K31/714 A61K38/06 A61P1/16 

FIELD: pharmaceutics.

SUBSTANCE: invention refers to pharmaceutical industry, namely to a pharmaceutical composition for parenteral drop introduction, intended for treating non-infectious liver diseases. Proposed composition comprises a complex of active substances: 10–30 mg of sodium flavinadenine dinucleotide, 100 mg of nicotinamide adenine dinucleotide phosphate, 60 mg pyridoxalphosphate hydrate, 1 mg methylcobalamin, 600–3,000 mg glutathione, 12.5 mg of orotic acid, 12.5 mg of adenosine phosphate, 106 mg of monoammonium glycyrrhizinate (80 mg in terms of glycyrrhizinic acid), 750 mg of L-methionine, 200 mg of L-cysteine hydrochloride, 800 mg of L-glycine, 100–250 mg of dexpanthenol, 1–3 mg of biotin, 15 mg of folic acid, 25 mg of alpha-lipoic (thioctic) acid, 25 mg of Ubidecarenone, 1,000 mg of ascorbic acid and distilled water (up to 500 ml).

EFFECT: invention provides extending the range of products for treating pathological processes non-infectious genesis in liver.

1 cl, 3 ex